Summary National Jewish researchers, studying the molecular mechanisms of steroid resistance in asthma and other immune system-mediated conditions, have identified specific proteins that appear to trigger or exacerbate steroid resistance, as well as compounds that can be used to restore sensitivity to steroids. Diagnostic tests for steroid resistance are available.
Technology is ready for testing in human subjects using readily available therapeutic formulations.
5,266,312 issued on use of gamma interferon for treatment of steroid resistant asthma - U.S. Patent No. Licensing Potential - Technologies are available for licensing. No part of this publication may be redistributed in any form without prior permission. Terms and conditions for users . Privacy policy .